home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9408a.zip
/
M9480217.TXT
< prev
next >
Wrap
Text File
|
1994-08-09
|
3KB
|
43 lines
Document 0217
DOCN M9480217
TI Adverse effects and drug interactions of clinical importance with
antiviral drugs.
DT 9410
AU Morris DJ; Department of Pathological Sciences, Medical School,
Manchester,; England.
SO Drug Saf. 1994 Apr;10(4):281-91. Unique Identifier : AIDSLINE
MED/94288920
AB Most antiviral drugs are nucleoside analogues with potential
teratogenic, embryotoxic, carcinogenic and antiproliferative activities.
They must be administered with caution during pregnancy, because some
are known teratogens (e.g. amantadine) and a similar propensity cannot
be entirely excluded for others (e.g. aciclovir). Their adverse effects
mostly involve bone marrow depression (e.g. granulocytopenia with
ganciclovir, anaemia with zidovudine) or neurotoxicity (e.g. seizures
with interferon-alpha, peripheral neuropathy with zalcitabine), although
gastrointestinal effects are also seen. Idiosyncratic reactions include
didanosine-induced acute pancreatitis. Only inosine pranobex is largely
free from toxicity. Idoxuridine must be administered topically, given
the severity of its systemic adverse effects. Drug interactions
involving antiviral agents mostly reflect shared toxicity with other
agents (e.g. neutropenia with ganciclovir and zidovudine, pancreatitis
with didanosine and alcohol), although renal excretion or hepatic
metabolism may be implicated. Given the possibility of severe adverse
reactions and drug interactions, antiviral chemotherapy should only be
used for potentially serious virus infections. Topical administration
avoids systemic adverse effects but not mutagenic risks, and may result
in exposure of individuals other than the patient (e.g. aerosolised
ribavirin).
DE Acyclovir/ADVERSE EFFECTS Amantadine/ADVERSE EFFECTS Antiviral
Agents/*ADVERSE EFFECTS AIDS-Related Opportunistic Infections/DRUG
THERAPY Didanosine/ADVERSE EFFECTS Drug Interactions
Foscarnet/ADVERSE EFFECTS Ganciclovir/ADVERSE EFFECTS Human
Interferon-alpha/ADVERSE EFFECTS Ribavirin/ADVERSE EFFECTS
Rimantadine/ADVERSE EFFECTS Vidarabine/ADVERSE EFFECTS
Zalcitabine/ADVERSE EFFECTS Zidovudine/ADVERSE EFFECTS JOURNAL ARTICLE
REVIEW REVIEW, TUTORIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).